[Table/Fig-1]:

Clinical and demographic data of patients.

Characteristics	Percentage
Age
<10	2(8%)
11-20	2(8 %)
21-30	1(4%)
31-50	15(60%) (p value <0.01)
51-60	2(8%)
>60	3(12%)
Sex:
Male	18(72%)
Female	7(28%)
Co-Morbidity
Diabetes	13(52%)
Solid Tumour	1(4%)
Haematological Malignancy	2(8%)
ICU Stay and Duration
YES	10(40%)
NO	15(60%)
<5	3(12%)
5-10 days	4(16%)
>10	3(12%)
Treatment with Anti-Fungals
Voriconazole	7(28%)
Posaconazole	2(8%)
Amphotericin B(Conventional)	9(36%)
Amphotericin B(Liposomal)	1(4%)
None	3(12%)
Both	3(12%)
Status After Treatment
Improved	21(95%)
Expired	1(5%)
On follow-up	15/21(71%)
Lost to follow-up	6/21(29%)